OKYO Pharma (OKYO) Shares Outstanding (Weighted Average) (2021 - 2025)

OKYO Pharma (OKYO) has 4 years of Shares Outstanding (Weighted Average) data on file, last reported at $151.2 million in Q3 2025.

• Shares Outstanding (Weighted Average) for Q3 2025 came in at $151.2 million, up 304.11% year-over-year; the trailing twelve-month figure through Sep 2025 was $151.2 million (up 304.11% YoY), and the FY2025 annual result was $146.7 million, up 340.11% from the prior year.
• Shares Outstanding (Weighted Average) climbed to $151.2 million in Q3 2025 per OKYO's latest filing, from $146.7 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $151.2 million in Q3 2025 and troughed at $10.4 million in Q1 2021.
• A 4-year average of $77.1 million and a median of $37.4 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) tumbled 72.36% in 2024, then soared 340.11% in 2025.
• A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $10.4 million in 2021, then surged by 1207.95% to $135.4 million in 2023, then plunged by 72.36% to $37.4 million in 2024, then surged by 304.11% to $151.2 million in 2025.
• Business Quant data shows OKYO's Shares Outstanding (Weighted Average) at $151.2 million in Q3 2025, $146.7 million in Q1 2025, and $37.4 million in Q3 2024.